SlideShare a Scribd company logo
1 of 10
Marie Germain
With the elderly population living longer, the rise of
polypharmacy is becoming more common. Polypharmacy, the
state of being in more than 5 medications causes high risk in the
health of the patient and consequently becomes a huge concern
for medical practitioners (Golchin, Frank, Vince, Isham &
Meropol, 2015). Polypharmacy is common among the elderly
people especially because of high morbidity factors. As a result,
it becomes medically necessary to be on multiple medications,
although it is not advisable especially given the high risk the
patient is put into. The question becomes does the benefits
outweigh the consequences? It is important to understand these
risks and possible interventions to prevent, treat and respond to
polypharmacy risks in order to improve patient outcomes.
Among the risk associated with polypharmacy are
reactions between drug to drug reactions and increased risk of
morbidity. Approximately 40% of the older adults are on
multiple prescription drugs, while half of these are at a high
risk of experiencing the risks associated with polypharmacy
(Rossi, Feske, Shaffer & Kreutzer, 2017). Reaction to drugs can
cause effects such as allergic reactions and other serious
adverse effects that can be fatal (Azhagesan, 2017). Also, drugs
may react with each other resulting in one having a greater
effect than the other, and possibly hindering it from the
intended action. Morbidity is the ultimate and most
unprecedented risk as death may occur on the patient following
immunity weakening.
As a health concern, practitioners need to respond to this
issue. The first response is to examine the patient’s accurate
medical history upon any given discharge. This is important in
examining previous medications and how they fared well with
the particular patient. This also helps to inspire the most
accurate medication (Rossi, Feske, Shaffer & Kreutzer, 2017).
Secondly, the medical practitioners need to reconcile
medications given to the patient (Azhagesan, 2017). This helps
to prevent the risk of drug to drug interactions, while adhering
to early intervention to help to prevent or deal with medical
issues.
Maritza Cosme
Risk Factors for Polypharmacy
Polypharmacy entails taking of 5 or more medicines.
Generally, polypharmacy in the elderly occurs because of three
factors: demographic factors, health factors, and access to
healthcare. It is more common among older patients and has
potential harms such as drug interactions and drug toxicity.
Polypharmacy is an area of concern for elderly because of
several reasons. Elderly people are at a greater risk for adverse
drug reactions (ADRs) because of the metabolic changes and
reduced drug clearance associated with ageing; this risk is
furthermore exacerbated by increasing the number of drugs
used. Polypharmacy is linked to increased risk of adverse drug
events in older people due to increased risk of drug interactions,
lack of adherence to medication regimes, susceptibility of older
people to side effects of medications, and physical changes
related to ageing causing difficulties in taking medications as
prescribed. One of the risk factors is frailty. Patients who are
frail are more likely to be having many health conditions that
can contribute to excessive polypharmacy. Another risk factor is
multimorbidity (Card, 2016; Ersoy, 2018). Patients who have
many chronic conditions may be have to take 5 or more
medicines to manage their conditions. Obesity is another risk
factor. Obese people may have risk factors for many health
conditions such as diabetes, heart disease, and high blood
pressure, among others (Ersoy, 2018). These conditions may
make them to take many medicines to manage them, therefore
resulting to polypharmacy. In the elderly, disorders that occur
as a result of ageing, frequently require treatment, resulting in
increased use of medications. Polypharmacy is common among
the elderly and although it can be therapeutic in nature, is
linked to adverse events such as falls.
Interventions to prevent polypharmacy and its complications
A nurse practitioner is central to the administration of
healthcare services. The nurse can play certain roles to prevent
polypharmacy and its complications. One intervention may
entail assessing for drug-drug interactions. If there are
interactions, there may be a need to eliminate some medicines.
Another intervention may include reviewing dosages. The
effects of the medicines may be due to excess dosages. The
reviewing of dosages can lead to a reduction in the number of
medicines that one takes. Another intervention is eliminating
duplicate medications (Johansson, 2017). Some medications
may serve the same purpose; and therefore, it is necessary to
eliminate some to reduce the burden on the patient. Exploring
non-pharmacological approaches may also be necessary. For
instance, if a patient has depression or anxiety, use of
psychotherapy and exercise may be a useful alternative to
medicines and therefore reduce the number of medicines that
one takes.
Guillermo
Polypharmacy
Indeed, polypharmacy in which patients take several medicines
to an extent that they result in complexities is a common
experience among the old people. Such a situation is as a result
of particular aspects which is discovered can solve the issue.
The common risk factors for polypharmacy among the older
individuals are gastric disturbances as well as gastrointestinal
diseases that induce a lot of adverse reactions which make
patients opt to taking gastrointestinal drugs. The intake of such
drugs them result in cascading of treatments and increment in
DDC. Additionally, painful conditions which the older adults
suffer including arthropathic, chronic, and neuropathic pain.
According to Word Health Organization (2019) chronic pain is
related with behavioral and somatic comorbidities encourages
the old adults to consume excess analgesic. Indeed, risk factors
such as the ones mentioned above trigger the increased cases of
polypharmacy.
As a Nurse Practitioner, I would proactively teach the
community especially old patients about sustainable and
suitable medication as well as lifestyle. According to WHO
(2019) unhealthy lifestyle causes multimorbidity among many
patients, hence educating the ole people on healthy foods,
proper health care, and housing as well as exercising helps
reduce polypharmacy and its effects. The second intervention is
to involve the patients into understanding the effect of using too
many medications, reporting side effects immediately they
happen, and using medication in the correct manner. Molokhia
& Majeed (2017) Opines that involving patients in the process
of medication, monitoring them as they start and continue using
the medication, as well as informing them on the right way to
take drugs and report on impacts serves in reducing risks of
polypharmacy. Therefore, the two interventions would suit me
well.
Daylamis
Risk Factor for Polypharmacy
Polypharmacy may lead to comorbidities mostly to elderly
people since its strongly related to age. Most of the aged people
suffers from multiple illness at the same time leading to the
taking more than one medication to cater for different sickness
(Cantlay, Glyn, & Barton, 2016). Patients with multiple
comorbidities have a high risk of polypharmacy since treating
the patient with various illnesses has become a general practice
in the health sector. In addition, most of the clinical officer’s
focus on the single disease at a time, excluding patients with
multiple conditions.
Polypharmacy increases the risk of poor behavior and
misunderstanding on medication to the patient. Most of the
patient lack proper knowledge of drugs and reliable on available
information or experience. This led to duplication or
unnecessary medication prescribed by medical staff who have
no previous medical history of the patient. The patient also
accesses medication from multiple providers that do not know
his other health condition.
Intervention to Prevent Polypharmacy
First is through identify the indication strategy that should be
implemented by any therapist and physician. The approach
involves identification or diagnosis before the medication is
given out to avoid the increased case of misappropriating
prescriptions in healthcare facilities (Fasipe, Akhideno,
Ibiyemi-Fasipe, & Idowu, 2018). It also the role of the patient
to ensure the information given is clearly communicated and in
the direction of use.
Another method is the integration of START (screening tool to
alert the doctor to the right treatment) technology in health care
facilities. The technology provides the physician with an
opportunity to evaluate and discontinues any prescribed
medication that poses a risk to polypharmacy.
Dailyn Gonzalez
Advanced Pharmacology
Polypharmacy refers to the use of more than one medication by
a patient. The exact number of medications that define
polypharmacy vary from one person to another and ranges from
five to ten drugs. There are various risk factors associated with
the condition. The first one is age. Polypharmacy is common in
old people. The elderly are more susceptible to experiencing the
condition since they have multiple diseases which require
varying prescriptions. The elderly are also at risk since their
bodies have high chances of experiencing drug events as a
result of metabolic changes and a reduction in drug clearance
capabilities (Abdulraheem, 2013).
According to Slater, White, Venables, & Frisher (2018), another
risk factor associated with polypharmacy is poverty or lower
wealth. People from lower social classes tend to use over the
counter drugs to treat themselves due to lack of funds to take
them to hospitals. As a result, they take more than one
medication for their conditions. Obesity is also believed to
increase the risk of polypharmacy. Obesity is usually associated
with a series of chronic heart diseases such as hypertension.
Therefore, obese people use multiple medications to treat
various diseases.
The first intervention towards preventing polypharmacy
involves drawing from palliative care. The intervention is
mostly applicable in very old people, and it entails
discontinuation of drugs being administered on the patient.
Another method entails conducting medication training during
transition care. An example of a transition case is discharging a
patient. Duplicate medications also need be to eliminated
(Dagli, & Sharma, 2014). The last method entails assessing a
patient for the presence of drug-drug interactions before
administering any medication. Therefore, as a practitioner, the
interventions which I would take to prevent polypharmacy
include training patients before they are discharged and
assessing them for drug-drug interactions before administering
medications.
Maylee
Polypharmacy
Some of the definitions concerning polypharmacy that can be
encountered in my readings can be more than one definition
aspect. The first description of polypharmacy is the utilization
of numerous pharmacies, which is a chief public health concern.
This happens as the multiple prescribers in the industry, the
ever readily available of supplements, and the use of OTC
medications are some of the experienced challenges affecting
the prescription for the aged population ( Chamberlain College
of Nursing, 2018). Secondly, numerous prescribers, as well as
care providers, the use of OTC drugs, the cost adherence, the
availability of supplements as well as the herbals, are still
problems affecting the prescriptions for the adults (Terrery &
Nicoteri, 2016). Moreover, the use of several medicine drugs is
what is referred to as polypharmacy, which usually affects the
older population experiencing multi-morbidity, results as one or
more medicine drugs can be employed as a therapeutic modality
to treat each condition experienced (Masnoon, Skakib, &
Caughey, 2017).
The self-medication is a risk factor which contributes to the
polypharmacy in most of the cases. The primary rationale here
is evidenced based on that most of the patients usually buy
medicine from the nearest local places as they do self-
prescriptions and purchase, and this increases the risk factors of
polypharmacy. Moreover, due to the rising status of the
economy and the escalation of the cost of medicinal drugs the
patients are often like to use the medicines that had been
prescribed for them in the past and this enhances the risks of
polypharmacy as a result of the self-medications (Maher,
Hanlon, & Hajjar, 2014),
The aspect of chronic comorbidities is a risk factor that results
in the use of polypharmacy. For example, if the patient has been
diagnosed with conditions such as diabetes, cancer, dementia,
cardiorespiratory illness, infectious diseases, these patients are
likely to be subjected to polypharmacy. Sometimes, when
patients have different care providers with separate chart sheets,
they are likely to subject the patient to polypharmacy (Maher,
Hanlon, & Hajjar, 2014).
Some of the interventions that I can take as nursing practitioner
is enhance a comprehensive review of the patient treatment
sheet to avoid an element of medication duplicate which might
occur during the transmission of the patient from one facility to
another one or even correctly check the information given to the
patient by the chemist to avoid polypharmacy issues. The brown
bag review technique is the strategy where the patient is
encouraged, carrying all medical history to allow the
comprehensive review to prevent the element of subjecting the
patient into polypharmacy (McGrath et al., 2017). Another
intervention strategy is to create a thorough follow up with the
patients. The planning aid at the time of doing a prescription of
medication as it provides a complete developed plan to monitor
and assess the patient regularly. The comprehensive follow up
method enables the patient to understand the effects and
symptoms that may results due to medication withdrawal as it
provides the necessary, which can cause the return of the
condition if the medication is not taken as per the prescription.
Risk Factors for Polypharmacy in the Elderly Population

More Related Content

Similar to Risk Factors for Polypharmacy in the Elderly Population

3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance3.3. The Reality of Non-Compliance
3.3. The Reality of Non-ComplianceTeleosis Institute
 
1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptxDrAniqaSundas
 
Adverse Drug Reactions Risk Factors, Epidemiology, and Management Strategies
Adverse Drug Reactions Risk Factors, Epidemiology, and Management StrategiesAdverse Drug Reactions Risk Factors, Epidemiology, and Management Strategies
Adverse Drug Reactions Risk Factors, Epidemiology, and Management Strategiesijtsrd
 
final duplication and misuse ppt
final duplication and misuse pptfinal duplication and misuse ppt
final duplication and misuse pptshahin ghori
 
Adverse drug reactions among critically ill patients at cairo
Adverse drug reactions among critically ill patients at cairoAdverse drug reactions among critically ill patients at cairo
Adverse drug reactions among critically ill patients at cairoAlexander Decker
 
Orientation To Pharmacology
Orientation To PharmacologyOrientation To Pharmacology
Orientation To PharmacologyTpetrici
 
Polypharm presentation
Polypharm presentationPolypharm presentation
Polypharm presentationLisa Tripp
 
Role of Human Resource Department in the Management of Drug Safety in Pharmac...
Role of Human Resource Department in the Management of Drug Safety in Pharmac...Role of Human Resource Department in the Management of Drug Safety in Pharmac...
Role of Human Resource Department in the Management of Drug Safety in Pharmac...ImtiajChowdhuryEham
 
perception and practice of self-medication among student of Yaba college of E...
perception and practice of self-medication among student of Yaba college of E...perception and practice of self-medication among student of Yaba college of E...
perception and practice of self-medication among student of Yaba college of E...Enwere Enweremchi David
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingTHUSHARA MOHAN
 
Polypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTPolypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTZeshan Ahmed
 
Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Ahmad Ali
 
Tabloski ch06 lecture
Tabloski ch06 lectureTabloski ch06 lecture
Tabloski ch06 lecturestanbridge
 
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics Pharmacogenomics, Pharmacogenetics and Pharmacokinetics
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics Zohaib HUSSAIN
 
Metformin Underused in Patients With Prediabetes
Metformin Underused in Patients With PrediabetesMetformin Underused in Patients With Prediabetes
Metformin Underused in Patients With Prediabetesboringevidence640
 

Similar to Risk Factors for Polypharmacy in the Elderly Population (20)

3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance
 
1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx1591115199267_Pharmacovigilance.pptx
1591115199267_Pharmacovigilance.pptx
 
Adverse Drug Reactions Risk Factors, Epidemiology, and Management Strategies
Adverse Drug Reactions Risk Factors, Epidemiology, and Management StrategiesAdverse Drug Reactions Risk Factors, Epidemiology, and Management Strategies
Adverse Drug Reactions Risk Factors, Epidemiology, and Management Strategies
 
Cia 5-075
Cia 5-075Cia 5-075
Cia 5-075
 
final duplication and misuse ppt
final duplication and misuse pptfinal duplication and misuse ppt
final duplication and misuse ppt
 
Adverse drug reactions among critically ill patients at cairo
Adverse drug reactions among critically ill patients at cairoAdverse drug reactions among critically ill patients at cairo
Adverse drug reactions among critically ill patients at cairo
 
Orientation To Pharmacology
Orientation To PharmacologyOrientation To Pharmacology
Orientation To Pharmacology
 
Polypharmacy
PolypharmacyPolypharmacy
Polypharmacy
 
Polypharm presentation
Polypharm presentationPolypharm presentation
Polypharm presentation
 
Role of Human Resource Department in the Management of Drug Safety in Pharmac...
Role of Human Resource Department in the Management of Drug Safety in Pharmac...Role of Human Resource Department in the Management of Drug Safety in Pharmac...
Role of Human Resource Department in the Management of Drug Safety in Pharmac...
 
perception and practice of self-medication among student of Yaba college of E...
perception and practice of self-medication among student of Yaba college of E...perception and practice of self-medication among student of Yaba college of E...
perception and practice of self-medication among student of Yaba college of E...
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Adverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reportingAdverse drug reaction monitoring and reporting
Adverse drug reaction monitoring and reporting
 
Polypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETTPolypharmacy resource_JAN 15_NINA BARNETT
Polypharmacy resource_JAN 15_NINA BARNETT
 
Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)
 
Polypharmacy and medication errors
Polypharmacy and medication errorsPolypharmacy and medication errors
Polypharmacy and medication errors
 
Tabloski ch06 lecture
Tabloski ch06 lectureTabloski ch06 lecture
Tabloski ch06 lecture
 
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics Pharmacogenomics, Pharmacogenetics and Pharmacokinetics
Pharmacogenomics, Pharmacogenetics and Pharmacokinetics
 
Volume106
Volume106Volume106
Volume106
 
Metformin Underused in Patients With Prediabetes
Metformin Underused in Patients With PrediabetesMetformin Underused in Patients With Prediabetes
Metformin Underused in Patients With Prediabetes
 

More from alfredacavx97

Continually in our changing society we are learning how to interact .docx
Continually in our changing society we are learning how to interact .docxContinually in our changing society we are learning how to interact .docx
Continually in our changing society we are learning how to interact .docxalfredacavx97
 
Context There are four main categories of computer crimeComput.docx
Context There are four main categories of computer crimeComput.docxContext There are four main categories of computer crimeComput.docx
Context There are four main categories of computer crimeComput.docxalfredacavx97
 
Continue to use the case study  (A&D High Tech) and Risk Management .docx
Continue to use the case study  (A&D High Tech) and Risk Management .docxContinue to use the case study  (A&D High Tech) and Risk Management .docx
Continue to use the case study  (A&D High Tech) and Risk Management .docxalfredacavx97
 
Continue to use the case study, evaluate, and assess risk. Use quali.docx
Continue to use the case study, evaluate, and assess risk. Use quali.docxContinue to use the case study, evaluate, and assess risk. Use quali.docx
Continue to use the case study, evaluate, and assess risk. Use quali.docxalfredacavx97
 
CONTEXT ASSIGNMENT # 6For this assignment, we are going to take .docx
CONTEXT ASSIGNMENT # 6For this assignment, we are going to take .docxCONTEXT ASSIGNMENT # 6For this assignment, we are going to take .docx
CONTEXT ASSIGNMENT # 6For this assignment, we are going to take .docxalfredacavx97
 
Media and SocietyMedia HistoryJOHN DEWEY – 185.docx
Media and SocietyMedia HistoryJOHN DEWEY – 185.docxMedia and SocietyMedia HistoryJOHN DEWEY – 185.docx
Media and SocietyMedia HistoryJOHN DEWEY – 185.docxalfredacavx97
 
Coping with Terrorism  Is the United States making progress in re.docx
Coping with Terrorism  Is the United States making progress in re.docxCoping with Terrorism  Is the United States making progress in re.docx
Coping with Terrorism  Is the United States making progress in re.docxalfredacavx97
 
MEDIA AND DIVERSITY IN CULTURECOM-530 MEDIA AND DIVE.docx
MEDIA AND DIVERSITY IN CULTURECOM-530 MEDIA AND DIVE.docxMEDIA AND DIVERSITY IN CULTURECOM-530 MEDIA AND DIVE.docx
MEDIA AND DIVERSITY IN CULTURECOM-530 MEDIA AND DIVE.docxalfredacavx97
 
Medeiros LNB de, Silva DR da, Guedes CDFS et al. .docx
Medeiros LNB de, Silva DR da, Guedes CDFS et al.              .docxMedeiros LNB de, Silva DR da, Guedes CDFS et al.              .docx
Medeiros LNB de, Silva DR da, Guedes CDFS et al. .docxalfredacavx97
 
Measuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxMeasuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxalfredacavx97
 
Meaningfulness vs. S.docx
Meaningfulness vs. S.docxMeaningfulness vs. S.docx
Meaningfulness vs. S.docxalfredacavx97
 
Contributing to the Team’s Work Score 20 pts.20 - 25 pts..docx
Contributing to the Team’s Work Score  20 pts.20 - 25 pts..docxContributing to the Team’s Work Score  20 pts.20 - 25 pts..docx
Contributing to the Team’s Work Score 20 pts.20 - 25 pts..docxalfredacavx97
 
Measuring Performance at Intuit A Value-Added Component in ERM Pr.docx
Measuring Performance at Intuit A Value-Added Component in ERM Pr.docxMeasuring Performance at Intuit A Value-Added Component in ERM Pr.docx
Measuring Performance at Intuit A Value-Added Component in ERM Pr.docxalfredacavx97
 
Controversial Issue in Microbiology Assignment Use of antibacte.docx
Controversial Issue in Microbiology Assignment Use of antibacte.docxControversial Issue in Microbiology Assignment Use of antibacte.docx
Controversial Issue in Microbiology Assignment Use of antibacte.docxalfredacavx97
 
Control measures for noncommunicable disease may start with basic sc.docx
Control measures for noncommunicable disease may start with basic sc.docxControl measures for noncommunicable disease may start with basic sc.docx
Control measures for noncommunicable disease may start with basic sc.docxalfredacavx97
 
Contrasting Africa and Europes economic development.Why did Europ.docx
Contrasting Africa and Europes economic development.Why did Europ.docxContrasting Africa and Europes economic development.Why did Europ.docx
Contrasting Africa and Europes economic development.Why did Europ.docxalfredacavx97
 
Measure the dependence of the resistance in the spinel Lu2V2O7 on .docx
Measure the dependence of the resistance in the spinel Lu2V2O7 on .docxMeasure the dependence of the resistance in the spinel Lu2V2O7 on .docx
Measure the dependence of the resistance in the spinel Lu2V2O7 on .docxalfredacavx97
 
Measures of Similaritv and Dissimilaritv 65the comparison .docx
Measures of Similaritv and Dissimilaritv 65the comparison .docxMeasures of Similaritv and Dissimilaritv 65the comparison .docx
Measures of Similaritv and Dissimilaritv 65the comparison .docxalfredacavx97
 
MDS 4100 Communication Law Case Study Privacy CASE .docx
MDS 4100 Communication Law Case Study Privacy CASE .docxMDS 4100 Communication Law Case Study Privacy CASE .docx
MDS 4100 Communication Law Case Study Privacy CASE .docxalfredacavx97
 
MDDtoDOC - GSS2018 Ballot 1 - English Table Of Contents.docx
MDDtoDOC - GSS2018 Ballot 1 - English  Table Of Contents.docxMDDtoDOC - GSS2018 Ballot 1 - English  Table Of Contents.docx
MDDtoDOC - GSS2018 Ballot 1 - English Table Of Contents.docxalfredacavx97
 

More from alfredacavx97 (20)

Continually in our changing society we are learning how to interact .docx
Continually in our changing society we are learning how to interact .docxContinually in our changing society we are learning how to interact .docx
Continually in our changing society we are learning how to interact .docx
 
Context There are four main categories of computer crimeComput.docx
Context There are four main categories of computer crimeComput.docxContext There are four main categories of computer crimeComput.docx
Context There are four main categories of computer crimeComput.docx
 
Continue to use the case study  (A&D High Tech) and Risk Management .docx
Continue to use the case study  (A&D High Tech) and Risk Management .docxContinue to use the case study  (A&D High Tech) and Risk Management .docx
Continue to use the case study  (A&D High Tech) and Risk Management .docx
 
Continue to use the case study, evaluate, and assess risk. Use quali.docx
Continue to use the case study, evaluate, and assess risk. Use quali.docxContinue to use the case study, evaluate, and assess risk. Use quali.docx
Continue to use the case study, evaluate, and assess risk. Use quali.docx
 
CONTEXT ASSIGNMENT # 6For this assignment, we are going to take .docx
CONTEXT ASSIGNMENT # 6For this assignment, we are going to take .docxCONTEXT ASSIGNMENT # 6For this assignment, we are going to take .docx
CONTEXT ASSIGNMENT # 6For this assignment, we are going to take .docx
 
Media and SocietyMedia HistoryJOHN DEWEY – 185.docx
Media and SocietyMedia HistoryJOHN DEWEY – 185.docxMedia and SocietyMedia HistoryJOHN DEWEY – 185.docx
Media and SocietyMedia HistoryJOHN DEWEY – 185.docx
 
Coping with Terrorism  Is the United States making progress in re.docx
Coping with Terrorism  Is the United States making progress in re.docxCoping with Terrorism  Is the United States making progress in re.docx
Coping with Terrorism  Is the United States making progress in re.docx
 
MEDIA AND DIVERSITY IN CULTURECOM-530 MEDIA AND DIVE.docx
MEDIA AND DIVERSITY IN CULTURECOM-530 MEDIA AND DIVE.docxMEDIA AND DIVERSITY IN CULTURECOM-530 MEDIA AND DIVE.docx
MEDIA AND DIVERSITY IN CULTURECOM-530 MEDIA AND DIVE.docx
 
Medeiros LNB de, Silva DR da, Guedes CDFS et al. .docx
Medeiros LNB de, Silva DR da, Guedes CDFS et al.              .docxMedeiros LNB de, Silva DR da, Guedes CDFS et al.              .docx
Medeiros LNB de, Silva DR da, Guedes CDFS et al. .docx
 
Measuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxMeasuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docx
 
Meaningfulness vs. S.docx
Meaningfulness vs. S.docxMeaningfulness vs. S.docx
Meaningfulness vs. S.docx
 
Contributing to the Team’s Work Score 20 pts.20 - 25 pts..docx
Contributing to the Team’s Work Score  20 pts.20 - 25 pts..docxContributing to the Team’s Work Score  20 pts.20 - 25 pts..docx
Contributing to the Team’s Work Score 20 pts.20 - 25 pts..docx
 
Measuring Performance at Intuit A Value-Added Component in ERM Pr.docx
Measuring Performance at Intuit A Value-Added Component in ERM Pr.docxMeasuring Performance at Intuit A Value-Added Component in ERM Pr.docx
Measuring Performance at Intuit A Value-Added Component in ERM Pr.docx
 
Controversial Issue in Microbiology Assignment Use of antibacte.docx
Controversial Issue in Microbiology Assignment Use of antibacte.docxControversial Issue in Microbiology Assignment Use of antibacte.docx
Controversial Issue in Microbiology Assignment Use of antibacte.docx
 
Control measures for noncommunicable disease may start with basic sc.docx
Control measures for noncommunicable disease may start with basic sc.docxControl measures for noncommunicable disease may start with basic sc.docx
Control measures for noncommunicable disease may start with basic sc.docx
 
Contrasting Africa and Europes economic development.Why did Europ.docx
Contrasting Africa and Europes economic development.Why did Europ.docxContrasting Africa and Europes economic development.Why did Europ.docx
Contrasting Africa and Europes economic development.Why did Europ.docx
 
Measure the dependence of the resistance in the spinel Lu2V2O7 on .docx
Measure the dependence of the resistance in the spinel Lu2V2O7 on .docxMeasure the dependence of the resistance in the spinel Lu2V2O7 on .docx
Measure the dependence of the resistance in the spinel Lu2V2O7 on .docx
 
Measures of Similaritv and Dissimilaritv 65the comparison .docx
Measures of Similaritv and Dissimilaritv 65the comparison .docxMeasures of Similaritv and Dissimilaritv 65the comparison .docx
Measures of Similaritv and Dissimilaritv 65the comparison .docx
 
MDS 4100 Communication Law Case Study Privacy CASE .docx
MDS 4100 Communication Law Case Study Privacy CASE .docxMDS 4100 Communication Law Case Study Privacy CASE .docx
MDS 4100 Communication Law Case Study Privacy CASE .docx
 
MDDtoDOC - GSS2018 Ballot 1 - English Table Of Contents.docx
MDDtoDOC - GSS2018 Ballot 1 - English  Table Of Contents.docxMDDtoDOC - GSS2018 Ballot 1 - English  Table Of Contents.docx
MDDtoDOC - GSS2018 Ballot 1 - English Table Of Contents.docx
 

Recently uploaded

Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 

Recently uploaded (20)

Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 

Risk Factors for Polypharmacy in the Elderly Population

  • 1. Marie Germain With the elderly population living longer, the rise of polypharmacy is becoming more common. Polypharmacy, the state of being in more than 5 medications causes high risk in the health of the patient and consequently becomes a huge concern for medical practitioners (Golchin, Frank, Vince, Isham & Meropol, 2015). Polypharmacy is common among the elderly people especially because of high morbidity factors. As a result, it becomes medically necessary to be on multiple medications, although it is not advisable especially given the high risk the patient is put into. The question becomes does the benefits outweigh the consequences? It is important to understand these risks and possible interventions to prevent, treat and respond to polypharmacy risks in order to improve patient outcomes. Among the risk associated with polypharmacy are reactions between drug to drug reactions and increased risk of morbidity. Approximately 40% of the older adults are on multiple prescription drugs, while half of these are at a high risk of experiencing the risks associated with polypharmacy (Rossi, Feske, Shaffer & Kreutzer, 2017). Reaction to drugs can cause effects such as allergic reactions and other serious adverse effects that can be fatal (Azhagesan, 2017). Also, drugs may react with each other resulting in one having a greater effect than the other, and possibly hindering it from the intended action. Morbidity is the ultimate and most unprecedented risk as death may occur on the patient following immunity weakening. As a health concern, practitioners need to respond to this issue. The first response is to examine the patient’s accurate medical history upon any given discharge. This is important in examining previous medications and how they fared well with the particular patient. This also helps to inspire the most accurate medication (Rossi, Feske, Shaffer & Kreutzer, 2017). Secondly, the medical practitioners need to reconcile
  • 2. medications given to the patient (Azhagesan, 2017). This helps to prevent the risk of drug to drug interactions, while adhering to early intervention to help to prevent or deal with medical issues. Maritza Cosme Risk Factors for Polypharmacy Polypharmacy entails taking of 5 or more medicines. Generally, polypharmacy in the elderly occurs because of three factors: demographic factors, health factors, and access to healthcare. It is more common among older patients and has potential harms such as drug interactions and drug toxicity. Polypharmacy is an area of concern for elderly because of several reasons. Elderly people are at a greater risk for adverse drug reactions (ADRs) because of the metabolic changes and reduced drug clearance associated with ageing; this risk is furthermore exacerbated by increasing the number of drugs used. Polypharmacy is linked to increased risk of adverse drug events in older people due to increased risk of drug interactions, lack of adherence to medication regimes, susceptibility of older people to side effects of medications, and physical changes related to ageing causing difficulties in taking medications as prescribed. One of the risk factors is frailty. Patients who are frail are more likely to be having many health conditions that
  • 3. can contribute to excessive polypharmacy. Another risk factor is multimorbidity (Card, 2016; Ersoy, 2018). Patients who have many chronic conditions may be have to take 5 or more medicines to manage their conditions. Obesity is another risk factor. Obese people may have risk factors for many health conditions such as diabetes, heart disease, and high blood pressure, among others (Ersoy, 2018). These conditions may make them to take many medicines to manage them, therefore resulting to polypharmacy. In the elderly, disorders that occur as a result of ageing, frequently require treatment, resulting in increased use of medications. Polypharmacy is common among the elderly and although it can be therapeutic in nature, is linked to adverse events such as falls. Interventions to prevent polypharmacy and its complications A nurse practitioner is central to the administration of healthcare services. The nurse can play certain roles to prevent polypharmacy and its complications. One intervention may entail assessing for drug-drug interactions. If there are interactions, there may be a need to eliminate some medicines. Another intervention may include reviewing dosages. The effects of the medicines may be due to excess dosages. The reviewing of dosages can lead to a reduction in the number of medicines that one takes. Another intervention is eliminating duplicate medications (Johansson, 2017). Some medications may serve the same purpose; and therefore, it is necessary to eliminate some to reduce the burden on the patient. Exploring non-pharmacological approaches may also be necessary. For instance, if a patient has depression or anxiety, use of psychotherapy and exercise may be a useful alternative to medicines and therefore reduce the number of medicines that one takes.
  • 4. Guillermo Polypharmacy Indeed, polypharmacy in which patients take several medicines to an extent that they result in complexities is a common experience among the old people. Such a situation is as a result of particular aspects which is discovered can solve the issue. The common risk factors for polypharmacy among the older individuals are gastric disturbances as well as gastrointestinal diseases that induce a lot of adverse reactions which make patients opt to taking gastrointestinal drugs. The intake of such drugs them result in cascading of treatments and increment in DDC. Additionally, painful conditions which the older adults suffer including arthropathic, chronic, and neuropathic pain. According to Word Health Organization (2019) chronic pain is related with behavioral and somatic comorbidities encourages the old adults to consume excess analgesic. Indeed, risk factors such as the ones mentioned above trigger the increased cases of polypharmacy. As a Nurse Practitioner, I would proactively teach the community especially old patients about sustainable and suitable medication as well as lifestyle. According to WHO (2019) unhealthy lifestyle causes multimorbidity among many patients, hence educating the ole people on healthy foods, proper health care, and housing as well as exercising helps reduce polypharmacy and its effects. The second intervention is to involve the patients into understanding the effect of using too many medications, reporting side effects immediately they happen, and using medication in the correct manner. Molokhia & Majeed (2017) Opines that involving patients in the process of medication, monitoring them as they start and continue using the medication, as well as informing them on the right way to take drugs and report on impacts serves in reducing risks of polypharmacy. Therefore, the two interventions would suit me well.
  • 5. Daylamis Risk Factor for Polypharmacy Polypharmacy may lead to comorbidities mostly to elderly people since its strongly related to age. Most of the aged people suffers from multiple illness at the same time leading to the taking more than one medication to cater for different sickness (Cantlay, Glyn, & Barton, 2016). Patients with multiple comorbidities have a high risk of polypharmacy since treating the patient with various illnesses has become a general practice in the health sector. In addition, most of the clinical officer’s focus on the single disease at a time, excluding patients with multiple conditions. Polypharmacy increases the risk of poor behavior and misunderstanding on medication to the patient. Most of the patient lack proper knowledge of drugs and reliable on available information or experience. This led to duplication or unnecessary medication prescribed by medical staff who have no previous medical history of the patient. The patient also accesses medication from multiple providers that do not know his other health condition. Intervention to Prevent Polypharmacy
  • 6. First is through identify the indication strategy that should be implemented by any therapist and physician. The approach involves identification or diagnosis before the medication is given out to avoid the increased case of misappropriating prescriptions in healthcare facilities (Fasipe, Akhideno, Ibiyemi-Fasipe, & Idowu, 2018). It also the role of the patient to ensure the information given is clearly communicated and in the direction of use. Another method is the integration of START (screening tool to alert the doctor to the right treatment) technology in health care facilities. The technology provides the physician with an opportunity to evaluate and discontinues any prescribed medication that poses a risk to polypharmacy. Dailyn Gonzalez Advanced Pharmacology Polypharmacy refers to the use of more than one medication by
  • 7. a patient. The exact number of medications that define polypharmacy vary from one person to another and ranges from five to ten drugs. There are various risk factors associated with the condition. The first one is age. Polypharmacy is common in old people. The elderly are more susceptible to experiencing the condition since they have multiple diseases which require varying prescriptions. The elderly are also at risk since their bodies have high chances of experiencing drug events as a result of metabolic changes and a reduction in drug clearance capabilities (Abdulraheem, 2013). According to Slater, White, Venables, & Frisher (2018), another risk factor associated with polypharmacy is poverty or lower wealth. People from lower social classes tend to use over the counter drugs to treat themselves due to lack of funds to take them to hospitals. As a result, they take more than one medication for their conditions. Obesity is also believed to increase the risk of polypharmacy. Obesity is usually associated with a series of chronic heart diseases such as hypertension. Therefore, obese people use multiple medications to treat various diseases. The first intervention towards preventing polypharmacy involves drawing from palliative care. The intervention is mostly applicable in very old people, and it entails discontinuation of drugs being administered on the patient. Another method entails conducting medication training during transition care. An example of a transition case is discharging a patient. Duplicate medications also need be to eliminated (Dagli, & Sharma, 2014). The last method entails assessing a patient for the presence of drug-drug interactions before administering any medication. Therefore, as a practitioner, the interventions which I would take to prevent polypharmacy include training patients before they are discharged and assessing them for drug-drug interactions before administering medications.
  • 8. Maylee Polypharmacy Some of the definitions concerning polypharmacy that can be encountered in my readings can be more than one definition aspect. The first description of polypharmacy is the utilization of numerous pharmacies, which is a chief public health concern. This happens as the multiple prescribers in the industry, the ever readily available of supplements, and the use of OTC medications are some of the experienced challenges affecting the prescription for the aged population ( Chamberlain College of Nursing, 2018). Secondly, numerous prescribers, as well as care providers, the use of OTC drugs, the cost adherence, the availability of supplements as well as the herbals, are still problems affecting the prescriptions for the adults (Terrery & Nicoteri, 2016). Moreover, the use of several medicine drugs is what is referred to as polypharmacy, which usually affects the older population experiencing multi-morbidity, results as one or more medicine drugs can be employed as a therapeutic modality to treat each condition experienced (Masnoon, Skakib, & Caughey, 2017). The self-medication is a risk factor which contributes to the polypharmacy in most of the cases. The primary rationale here is evidenced based on that most of the patients usually buy medicine from the nearest local places as they do self-
  • 9. prescriptions and purchase, and this increases the risk factors of polypharmacy. Moreover, due to the rising status of the economy and the escalation of the cost of medicinal drugs the patients are often like to use the medicines that had been prescribed for them in the past and this enhances the risks of polypharmacy as a result of the self-medications (Maher, Hanlon, & Hajjar, 2014), The aspect of chronic comorbidities is a risk factor that results in the use of polypharmacy. For example, if the patient has been diagnosed with conditions such as diabetes, cancer, dementia, cardiorespiratory illness, infectious diseases, these patients are likely to be subjected to polypharmacy. Sometimes, when patients have different care providers with separate chart sheets, they are likely to subject the patient to polypharmacy (Maher, Hanlon, & Hajjar, 2014). Some of the interventions that I can take as nursing practitioner is enhance a comprehensive review of the patient treatment sheet to avoid an element of medication duplicate which might occur during the transmission of the patient from one facility to another one or even correctly check the information given to the patient by the chemist to avoid polypharmacy issues. The brown bag review technique is the strategy where the patient is encouraged, carrying all medical history to allow the comprehensive review to prevent the element of subjecting the patient into polypharmacy (McGrath et al., 2017). Another intervention strategy is to create a thorough follow up with the patients. The planning aid at the time of doing a prescription of medication as it provides a complete developed plan to monitor and assess the patient regularly. The comprehensive follow up method enables the patient to understand the effects and symptoms that may results due to medication withdrawal as it provides the necessary, which can cause the return of the condition if the medication is not taken as per the prescription.